Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

62 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q4 2021.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 41,477,196 shares of 101,996,650 outstanding shares and own 40.7% of the company stock.
Largest 10 shareholders include Canaan Partners XI LLC (9,663,645 shares), Atlas Venture Life Science Advisors, LLC (8,201,638 shares), RA CAPITAL MANAGEMENT, L.P. (4,965,588 shares), VANGUARD GROUP INC (3,034,777 shares), FMR LLC (2,830,353 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,202,533 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,580,978 shares), BOXER CAPITAL, LLC (1,189,943 shares), VIKING GLOBAL INVESTORS LP (1,157,424 shares), and JANUS HENDERSON GROUP PLC (1,022,548 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.